Changsha Central Hospital

Changsha, Hunan 410028

0 studies enrolling now · 4 studies all time

What they study most

Asthma, Cardiovascular Disease, Heart Failure

Studies at this site

• A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
• A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma — Completed
• Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early